Investing Profile

Simone Botti

InvestorVC
Junior Partner at INKEF Capital
inkefcapital.com/team/Tel Aviv, Israel
Photo of Simone Botti, Partner at INKEF Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
cb
$100K - $5.0M
$1.5M
4
€500M
CompanyStageDateRound SizeTotal Raised
Anavo Therapeutics
SeedMay 2023$9M
SeedApr 2021$24M
$33M
Co-investors: Therese Liechtenstein (MDC Ventures (formerly KBS Ventures)), Sakae Asanuma (Hotmail), Debora Dumont (Bioqube Ventures)
Precirix
Series BMar 2022$88M
$130M
Co-investors: Marten Steen (HealthCap), Ohad Hammer (Xtripe Angels), Jasper Bos (Forbion)
Cardior Pharmaceuticals
Series BAug 2021$75M
$75M
1st Lieutenant Ministero della DifesaPresent
Senior Consultant HotmailPresent
VP Technology Investments HotmailPresent
Senior Director Business Development Azenta Life SciencesPresent
Chairman HotmailPresent
VP, Business Development Moebius Medical Ltd.Present
Board Member HotmailPresent
Head Israel Bioincubator Fund M VenturesPresent
Board Member IATI - Israel Advanced Technology Industries AssociationPresent
President Israel-Italy Chamber of Commerce and IndustryPresent
Member Board Of Directors Anavo Therapeutics BVPresent
Member Board Of Directors Cardior PharmaceuticalsPresent
Member Board Of Directors PrecirixPresent
Member Board of Directors VarmXPresent
Member Board of Directors NMD Pharma A/SPresent
Mentor Invest In EquityPresent
CEO HotmailPresent
Managing Partner HotmailPresent
CEO Metabomed Ltd.Present
Junior Partner InkefPresent
Partner InkefPresent
Senior Partner, Head of Healthcare InkefPresent
Università degli Studi di Roma 'La Sapienza' Laurea Chemistry
Sapienza Università di Roma Laurea Chemistry
Weizmann Institute of Science Ph. D. Chemistry